Medtronic launches European pivotal trial for Engager


Medtronic Inc. (NYSE:MDT) launched a pivotal trial in support of a European regulatory win for its Engager transcatheter aortic valve implantation system.

The trial will include 150 people with severe aortic stenosis, a condition where the aortic valve doesn’t open fully and blood isn’t properly pumped out of the heart.